Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy

Area of Science:

• Ophthalmology
• Biomaterials Science
• Drug Delivery Systems

Background:

• Glaucoma treatment relies on topical eye drops, but face challenges like poor drug retention and bioavailability due to ocular barriers.
• Rapid nasolacrimal drainage, poor intraocular penetration, and frequent administration limit conventional glaucoma therapies, potentially causing cytotoxicity.

Purpose of the Study:

• To review the potential of injectable, natural biopolymer-based intravitreal hydrogels as a novel drug delivery system for glaucoma.
• To highlight the advantages of these hydrogels over conventional topical eye drop treatments.

Main Methods:

• Review of existing literature on intravitreal hydrogel drug delivery systems for glaucoma.
• Focus on natural biopolymers as biocompatible and biodegradable carriers.
• Analysis of hydrogels as nanocarriers for enhanced drug bioavailability and therapeutic efficacy.

Main Results:

• Injectable hydrogels administered intravitreally provide sustained drug release to the target site.
• Natural biopolymers offer biocompatibility, biodegradability, and minimal immunogenic responses, crucial for ocular applications.
• Hydrogels enhance drug bioavailability and therapeutic efficacy for anti-glaucomic drugs.

Conclusions:

• Natural biopolymer-based intravitreal hydrogels represent a promising advancement in glaucoma treatment.
• These systems overcome limitations of conventional eye drops, offering improved drug delivery and reduced ocular side effects.
• The biocompatibility and sustained release properties make them ideal for managing glaucoma effectively.